Sepsis-induced changes in behavioral stereotypy in rats; Involvement of tumor necrosis factor-alpha, oxidative stress, and dopamine turnover

Journal of Surgical Research

Volumn 186, Issue 1, 2014, Pages 262-268

  Erbaş, Oytun ^a   Taşkiran, Dilek ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

homovanillic acid; oxidative stress; Sepsis; sepsis associated encephalopathy; stereotypy; TNF

Indexed keywords

APOMORPHINE; DOPAMINE; HOMOVANILLIC ACID; MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM LIGATION; LIGATION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUNCTURE; RAT; SEPSIS; STEREOTYPY;

HOMOVANILLIC ACID; OXIDATIVE STRESS; SEPSIS; SEPSIS-ASSOCIATED ENCEPHALOPATHY; STEREOTYPY; TNF-Α;

ANIMALS; BRAIN; DOPAMINE; HOMOVANILLIC ACID; HUMANS; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; STEREOTYPED BEHAVIOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84890122426     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.08.001     Document Type: Article

References (44)

1. R.M. Kleinpell, B.T. Graves, and M.H. Ackerman Incidence, pathogenesis, and management of sepsis: an overview AACN Adv Crit Care 17 2006 385
2. L.J. Moore, and F.A. Moore Epidemiology of sepsis in surgical patients Surg Clin North Am 92 2012 1425
3. M.M. Levy, M.P. Fink, and J.C. Marshall 2001: SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Crit Care Med 31 2003 1250
4. T. Barichello, J.J. Fortunato, and A.M. Vitali Oxidative variables in the rat brain after sepsis induced by cecal ligation and perforation Crit Care Med 34 2006 886
5. Y. Wan, J. Xu, D. Ma, Y. Zeng, M. Cibelli, and M. Maze Postoperative impairment of cognitive function in rats: A possible role for cytokine-mediated inflammation in the hippocampus Anesthesiology 106 2007 436
6. H.A. Rosczyk, N.L. Sparkman, and R.W. Johnson Neuroinflammation and cognitive function in aged mice following minor surgery Exp Gerontol 43 2008 840
7. W.J. Ehlenbach, C.L. Hough, and P.K. Crane Association between acute care and critical illness hospitalization and cognitive function in older adults JAMA 303 2010 763
8. L.A. Eidelman, D. Putterman, C. Putterman, and C.L. Sprung The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities JAMA 275 1996 470
9. M. Ebersoldt, T. Sharshar, and D. Annane Sepsis-associated delirium Intensive Care Med 33 2007 941
10. E. Iacobone, J. Bailly-Salin, A. Polito, D. Friedman, R.D. Stevens, and T. Sharshar Sepsis-associated encephalopathy and its differential diagnosis Crit Care Med 37 2009 S331
11. F.G. Zampieri, M. Park, F.S. Machado, and L.C. Azevedo Sepsis-associated encephalopathy: not just delirium Clinics (Sao Paulo) 66 2011 1825
12. D.N. Nguyen, H. Spapen, and F. Su Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock Crit Care Med 34 2006 1967
13. N. Muller, and M. Ackenheil Psychoneuroimmunology and the cytokine action in the central nervous system: implications for psychiatric disorders Prog Neuropsychopharmacol Biol Psychiatry 22 1998 1
14. P. Lapchak A role for interleukin-2 in the regulation of striatal dopaminergic function Neuroreport 3 1992 165
15. S. Gatti, and T. Bartfai Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6 Brain Res 624 1993 291
16. O. Erbaş, A.M. Ergenoglu, A. Akdemir, A.O. Yeniel, and D. Taskiran Comparison of melatonin and oxytocin in the prevention of critical illness polyneuropathy in rats with experimentally induced sepsis J Surg Res 2012 10.1016/j.jss.2012.11.043
17. C. Toufekoula, V. Papadakis, and T. Tsaganos Compartmentalization of lipid peroxidation in sepsis by multidrug-resistant gram-negative bacteria: experimental and clinical evidence Crit Care 17 2013 R6
18. K.A. Wichterman, A.E. Baue, and I.H. Chaudry Sepsis and septic shock - a review of laboratory models and a proposal J Surg Res 29 1980 189
19. C. Reavill, A. Kettle, V. Holland, G. Riley, and T.P. Blackburn Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist Br J Pharmacol 126 1999 572
20. S.M. Dong, Y.G. Kim, J. Heo, M.K. Ji, J.W. Cho, and B.S. Kwak YKP1447, A novel potential atypical antipsychotic agent Korean J Physiol Pharmacol 13 2009 71
21. S. Amos, J. Abbah, B. Chindo, I. Edmond, L. Binda, and B. Adzu Neuropharmacological effects of the aqueous extract of Nauclea latifolia root bark in rats and mice J Ethnopharmacol 97 2005 53
22. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248
23. C.D. Lamar, R.A. Hurley, and K.H. Taber Sepsis-associated encephalopathy: review of the neuropsychiatric manifestations and cognitive outcome J Neuropsychiatry Clin Neurosci 3 2011 237
24. E.G. Gutierrez, W.A. Banks, and A.J. Kastin Murine tumor necrosis factor alpha is transported from blood to brain in the mouse J Neuroimmunol 47 1993 169
25. S. Nadeau, and S. Rivest Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier Neuroscience 93 1999 1449
26. J.J. Alexander, A. Jacob, P. Cunningham, L. Hensley, and R.J. Quigg TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1 Neurochem Int 52 2008 447
27. R. Yirmiya, and I. Goshen Immune modulation of learning, memory, neural plasticity and neurogenesis Brain Behav Immun 25 2011 181
28. B. Baune, M.L. Camara, H. Eyre, C. Jawahar, H. Anscomb, and H. Körner Tumour necrosis factor-alpha mediated mechanisms of cognitive dysfunction Transl Neurosci 3 2012 263
29. C.R. Plata-Salaman, Y. Oomura, and Y. Kai Tumor necrosis factor and interleukin-1beta: suppression of food intake by direct action in the central nervous system Brain Res 448 1988 106
30. S. Zalcman, L. Murray, D.G. Dyck, A.H. Greenberg, and D.M. Nance Interleukin-2 and -6 induce behavioral-activating effects in mice Brain Res 811 1998 111
31. S. Zalcman Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists Brain Res 944 2002 157
32. J.H. van Steijn, P. Nieboer, G.A. Hospers, E.G. de Vries, and N.H. Mulder Delirium after interleukin-2 and alpha-interferon therapy for renal cell carcinoma Anticancer Res 21 2001 3699
33. A. Reichenberg, R. Yirmiya, and A. Schuld Cytokine-associated emotional and cognitive disturbances in humans Arch Gen Psychiatry 58 2001 445
34. N. Terrando, C. Monaco, D. Ma, B.M. Foxwell, M. Feldmann, and M. Maze Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline Proc Natl Acad Sci U S A 107 2010 20518
35. H.M. Abd El-Gawad, and A.E. Khalifa Quercetin, coenzyme Q10, and L-canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain Pharmacol Res 43 2001 257
36. G. Sener, H. Toklu, and C. Kapucu Melatonin protects against oxidative organ injury in a rat model of sepsis Surg Today 35 2005 52
37. M.C. Papadopoulos, D.C. Davies, R.F. Moss, D. Tighe, and E.D. Bennett Pathophysiology of septic encephalopathy: a review Crit Care Med 28 2000 3019
38. R.C. van Der Mast Pathophysiology of delirium J Geriatr Psychiatry Neurol 11 1998 138
39. P.T. Trzepacz Delirium. Advances in diagnosis, pathophysiology, and treatment Psychiatr Clin North Am 19 1996 429
40. J.M. Flacker, V. Cummings, J.R. Mach Jr., K. Bettin, D.K. Kiely, and J. Wei The association of serum anticholinergic activity with delirium in elderly medical patients Am J Geriatr Psychiatry 6 1998 31
41. B.R. Sommer, L.C. Wise, and H.C. Kraemer Is dopamine administration possibly a risk factor for delirium? Crit Care Med 30 2002 1508
42. B.K. Young, R. Camicioli, and L. Ganzini Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment Drugs Aging 10 1997 367
43. I. Baeza, J. Castro-Fornieles, and R. Deulofeu Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients Psychiatry Res 168 2009 110
44. F. Amin, M. Davidson, and R.S. Kahn Assessment of the central dopaminergic index of plasma HVA in schizophrenia Schizophr Bull 21 1995 53